Skip to content

Neurolytic sympathectomy in management of cancer pain -Time effect; Prospective randomized multi-centric study

Neurolytic sympathectomy in management of cancer pain -Time effect; Prospective randomized multi-centric study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201311000619168
Enrollment
109
Registered
2013-08-14
Start date
2011-07-01
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer cancer pain

Interventions

early sympathectomy
late sympathectomy

Sponsors

it is own work for the authors
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients were suffering from visceral pain originating from in-operable abdominal or pelvic cancer reporting VAS from 40 to 70 after failure of non- opioids analgesics (1st step of WHO analgesic ladder), which had been histologically and radiologically proven. Pain localized to upper abdomen or pelvic region and described by patients as deep not superficial.

Exclusion criteria

Exclusion criteria: Patients had INR >1.5 or platelet count <50,000. infection at the site of needle entry, persistent hypotension, ascites whom had received previous neurolytic block or had psychiatric illness were excluded from the study. Patient was excluded if he/she developed a new type of pain as somatic or neuropathic pain at any stage of the study

Design outcomes

Primary

MeasureTime frame
VAS, total daily analgesic consumption

Secondary

MeasureTime frame
quality of life Questionnaire (QLQ- C30)

Countries

Egypt

Contacts

Public ContactHatem Abd el fatah

Assistant lecturer

hatem_elshora@yahoo.com0020403333666

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026